Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

Robert F. StoreyDepartment of Cardiovascular Science, University of Sheffield SheffieldUKCorrespondence[email protected]

Stefan K. JamesDepartment of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University UppsalaSweden

Agneta SiegbahnDepartment of Medical Sciences, Clinical Chemistry and Uppsala Clinical Research Center, Uppsala University UppsalaSweden

Christoph VarenhorstDepartment of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University UppsalaSweden

Claes HeldDepartment of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University UppsalaSweden

Joseph YcasAstraZeneca WilmingtonUSA

Steen E. HustedÅrhus University Hospital ÅrhusDenmark

Christopher P. CannonTIMI Study Group, Brigham and Women’s Hospital Boston, MAUSA

Richard C. BeckerDivision of Cardiovascular Health and Disease, and Heart, Lung and Vascular Institute, University of Cincinnati College of MedicineUSA

Ph Gabriel StegHopital Bichat, Assistance Publique-Höpitaux de Paris, and Departement Hospitalo Universitaire FIRE, Université Paris Diderot ParisFrance

Nils ÅsenbladDepartment of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University UppsalaSweden

Lars WallentinDepartment of Medical Sciences, Cardiology, and Uppsala Clinical Research Center, Uppsala University UppsalaSweden

show all

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date